CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-16 | Shah Smital Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-01-26 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award · Stock Option (right to buy) | +87,000 | 87,000 | ||
| 2022-01-26 | Cummings Keith Lamont Chief Financial Officer | Grant or award · Stock Option (right to buy) | +124,000 | 124,000 | ||
| 2022-01-26 | Hull Hans Chief Business Officer | Grant or award · Stock Option (right to buy) | +112,500 | 112,500 | ||
| 2022-01-26 | Lefebvre Eric Chief Medical Officer | Grant or award · Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2022-01-26 | Coulie Bernard President and CEO | Grant or award · Stock Option (right to buy) | +440,000 | 440,000 | ||
| 2021-09-03 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion | +20,000 | $2.08 | $42K | 67,621 |
| 2021-09-03 | Cummings Keith Lamont Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | −20,000 | 150,097 | ||
| 2021-06-29 | PYOTT DAVID E I Director | Grant or award · Stock Option (right to buy) | +13,286 | 13,286 | ||
| 2021-06-29 | Shah Smital Director | Grant or award · Stock Option (right to buy) | +13,286 | 13,286 | ||
| 2021-06-29 | PYOTT DAVID E I Director | Grant or award · Stock Option (right to buy) | +13,286 | 13,286 | ||
| 2021-06-29 | Huh Hoyoung Director | Grant or award · Stock Option (right to buy) | +13,286 | 13,286 | ||
| 2021-06-29 | HOMCY CHARLES J Director | Grant or award · Stock Option (right to buy) | +13,286 | 13,286 | ||
| 2021-06-29 | Exter Neil Director | Grant or award · Stock Option (right to buy) | +13,286 | 13,286 | ||
| 2021-06-29 | Curnutte John T Director | Grant or award · Stock Option (right to buy) | +13,286 | 13,286 | ||
| 2021-06-29 | CROWELL GAYLE A Director | Grant or award · Stock Option (right to buy) | +13,286 | 13,286 | ||
| 2021-06-29 | Bruhn Suzanne Louise Director | Grant or award · Stock Option (right to buy) | +13,286 | 13,286 | ||
| 2021-06-18 | Lefebvre Eric Chief Medical Officer | Sale | −8,750 | $28.62 | $250K | 140,830 |
| 2021-06-18 | Lefebvre Eric Chief Medical Officer | Sale | −3,728 | $29.43 | $110K | 137,102 |
| 2021-06-18 | Lefebvre Eric Chief Medical Officer | Sale | −22 | $30.23 | $665 | 137,080 |
Page 15 of 19 · 379 trades